NEW DAWN FOR MD : EXPLORING INNOVATIVE MUSCULAR DYSTROPHY TREATMENTS

For years, muscular dystrophy (MD) has presented a daunting challenge to patients and families worldwide. However, recent breakthroughs in research offer a symbol of hope for the future. Scientists are tirelessly working on innovative treatments that aim to not only alleviate symptoms but also to slow down the progression of this debilitating disea

This consequence indicates that identifying individuals that has a hypodopaminergic condition may well enable stratify the prescription of cognitive-boosting therapy immediately after TBI [forty two]. Amantadine, donepezil, and sertraline have also been documented to get successful for cognitive impairment after TBI, but extra significant-scale RCT